Founded in 1969, it is an enterprise and listed company engaged in the production and sales of pharmaceutical raw materials and preparations, food additives, feed additives, etc
Hubei Guangji Pharmaceutical Co., Ltd., founded in 1969, is a high-tech enterprise mainly engaged in the production and sales of pharmaceutical raw materials and preparations, food additives and feed additives, and was listed on the Shenzhen Stock Exchange in 1999 (stock code 000952). The total assets are 1.55 billion yuan and there are 1,320 employees (including 250 middle and senior engineering and technical personnel).
The company is based on high and new technology and adheres to the road of independent innovation. Through "introduction, digestion, absorption, improvement and innovation", the leading product riboflavin (i.e., vitamin B2) has been strengthened and expanded, ranking first in the world in production and sales, and establishing a strong brand of national VB industry.
The company is based on environmental protection to achieve energy conservation and emission reduction. It has invested 26 million yuan to build a sewage treatment plant with a daily treatment capacity of 2,500 tons of sewage; Invest more than 40 million yuan to build a multi-effect evaporation device, and the wastewater will be discharged up to standard after treatment; Invest 50 million yuan to replace 4 small boilers with 35 tons of circulating fluidized bed boilers, saving 13,800 tons of coal per year; using bag dust removal to control smoke and dust emissions below 50mg/m3, using new fermentation motors, saving more than 20 million kWh of electricity per year, and being listed as a national debt project for resource conservation and environmental protection by the National Development and Reform Commission.
In order to cultivate new profit growth points and further enhance the comprehensive competitiveness, the company acquired 2001 acres of land to build "Guangji Pharmaceutical Bio-Industrial Park", with a planned construction period of 6~8 years and a planned total investment of 25~3 billion yuan, focusing on investment in the construction of vitamins, amino acids, steroid drugs and other projects, the investment is being carried out step by step and in stages, and the first phase of the project is basically completed, and the first batch of products is expected to be put into production before the end of the year. The company also jointly invested in the establishment of Hubei Wison Pharmaceutical Co., Ltd. in Xianning with two partners to build an expansion project with an annual output of 1,000 tons of vitamin B6.
The company will further intensify the construction of the project, further refine the leading product riboflavin, add a new batch of new products with high added value and broad market prospects, vigorously explore the international and domestic markets, and strive to build a first-class pharmaceutical enterprise.
